← Eichor
Condition: Kidney Transplant Rejection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Kidney Transplant Rejection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Phase 2 · 7 location(s) · Singulera Therapeutics Inc. · NCT06552169Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
Phase 1/Phase 2 · 9 location(s) · Eledon Pharmaceuticals · NCT05027906Evaluation of the Efficacy of Dd-cfDNA in Routine Patient Care in Kidney Transplant Recipients"
NA · 6 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06406179Detection of Circulating Kidney DNA in Kidney Transplant Patients Facing an Episode of Graft Rejection
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06351488Use of Extracorporeal Photopheresis in Kidney Transplantation: Effects on Antibody-Mediated Rejection
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Besancon · NCT07663669Added Value of 18 FDG Pet-scanner in Diagnosis and Management of Subclinical Rejection in Kidney Transplant Patients
NA · 1 location(s) · University of Liege · NCT04702022Empagliflozin Treatment in Kidney Transplant Recipients
Phase 4 · 5 location(s) · VA Office of Research and Development · NCT06013865Impact of the Microbiota on the Likelihood of Renal Graft Rejection
Phase N/A · 9 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04736381Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
Phase 1 · 1 location(s) · University of California, Los Angeles · NCT05525507Tacrolimus Pharmacokinetic Subpopulations
Phase N/A · 2 location(s) · University Hospital, Grenoble · NCT04526431Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients
Phase N/A · 1 location(s) · Northwestern University · NCT01531257TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients
Phase 3 · 8 location(s) · Vastra Gotaland Region · NCT04561986TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients
Phase 3 · 25 location(s) · University of Sydney · NCT06474273Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated
NA · 1 location(s) · Hospices Civils de Lyon · NCT03955172Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
Phase N/A · 1 location(s) · Liverpool University Hospitals NHS Foundation Trust · NCT06025240Treatment of Antibody-Mediated Rejection (ABMR) With CarBel
Phase 1 · 10 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06918990A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients
Phase 3 · 13 location(s) · The University of Queensland · NCT05325008TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation
NA · 4 location(s) · Hospices Civils de Lyon · NCT06829719Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies
Phase 3 · 1 location(s) · University Hospital, Tours · NCT05385432Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab
NA · 1 location(s) · Shahid Beheshti University of Medical Sciences · NCT07006532Daratumumab for Late Antibody-Mediated Rejection
NA · 1 location(s) · University Hospital, Martin · NCT07081126Trifecta-Kidney cfDNA-MMDx Study
Phase N/A · 31 location(s) · University of Alberta · NCT04239703TreaT-Assay: the New Frontier for the Diagnosis of Acute Rejection in Kidney Transplantation
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06801262A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantati
Phase 2/Phase 3 · 26 location(s) · Sanofi · NCT07412470Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
Phase 2 · 55 location(s) · Alexion Pharmaceuticals, Inc. · NCT06744647Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection
Phase N/A · 1 location(s) · Loma Linda University · NCT05084768Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
Phase 1/Phase 2 · 1 location(s) · Jeffrey Veale, MD · NCT03707262Impact of ExtraCorporeal Phototherapy (ECP) on Auxiliary Follicular T-lymphocytes and Circulating B-lymphocytes During C
NA · 4 location(s) · University Hospital, Angers · NCT04870437Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
NA · 18 location(s) · Johns Hopkins University · NCT06263426Multi Center Observation of Sentinel Skin Graft for Detecting Acute Rejection After Renal Transplantation
Phase N/A · 3 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT05600634
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.